Feedback / Questions
BBO-8520 - BridgeBio Oncology Therap
BBO-11818 - BridgeBio Oncology Therap
BBO-10203 - BridgeBio Oncology Therap
https://www.globenewswire.com/news-release/2025/08/11/3131314/0/en/BBOT-Debuts-as-a-Publicly-Traded-Company-Focused-on-RAS-Pathway-Malignances-with-a-Potential-to-Realize-the-Full-Promise-of-KRAS-and-PI3K-Inhibition.html
Aug 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next